FDA Drug Application (021501) for CAPITAL SOLEIL 15 by LOREAL USA

Back to FDA Applications sponsored by LOREAL USA

Application Number021501
Product Number001
FormCREAM;TOPICAL
Dosage2%;3%;10%
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPITAL SOLEIL 15
Active IngredientAVOBENZONE; ECAMSULE; OCTOCRYLENE



Back to FDA Applications sponsored by LOREAL USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.